Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hidrocystoma × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2387 Pancreatic Neoplasms 1314 Colonic Neoplasms 1030 Stomach Neoplasms 1007 Carcinoma, Hepatocellular 1007 Rectal Neoplasms 877 Esophageal Neoplasms 648 Neoplasms 508 Liver Neoplasms 463 Breast Neoplasms 414 Neoplasm Metastasis 327 Lung Neoplasms 281 Carcinoma, Non-Small-Cell Lung 254 Gastrointestinal Neoplasms 250 Ovarian Neoplasms 220 Prostatic Neoplasms 200 Cholangiocarcinoma 183 Head and Neck Neoplasms 160 Gastrointestinal Stromal Tumors 158 Esophageal Squamous Cell Carcinoma 149 Barrett Esophagus 143 Melanoma 142 Adenocarcinoma Of Esophagus 136 Biliary Tract Neoplasms 133 Uterine Cervical Neoplasms 130 Gallbladder Neoplasms 120 Sarcoma 114 Urinary Bladder Neoplasms 113 Carcinoma, Renal Cell 112 Adenocarcinoma 111

Interventions

Sodium Chloride 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04932746 2023-02-17

RCT

Damascus University

Phase NA Completed

Gastrointestinal

Abscess, Esophageal Atresia, Hidrocystoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡